In the US, ABILIFY (aripiprazole systemic) is a member of the drug class atypical antipsychotics and is used to treat Agitated State, Autism, Bipolar Disorder, Depression, Major Depressive Disorder, Schizoaffective Disorder and Schizophrenia.
- Abilify Discmelt
- Abilify Maintena injection
- Abilify (Aripiprazole Injection)
- Abilify (Aripiprazole Oral Solution)
- Abilify (Aripiprazole Tablets)
- Abilify Maintena
- Abilify Intramuscular
- Abilify Mycite
Ingredient matches for ABILIFY
Aripiprazole is reported as an ingredient of ABILIFY in the following countries:
- Czech Republic
- Hong Kong
- New Zealand
- South Africa
- South Korea
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.